Evidence map›Paper›PMID 24813094›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2014

Radiation therapy quality assurance in clinical trials--Global Harmonisation Group.

Christos Melidis, Walter R Bosch, Joanna Izewska, Elena Fidarova, Eduardo Zubizarreta, Satoshi Ishikura, David Followill, James Galvin, Ying Xiao, Martin A Ebert and 8 more

Abstract readEditorial
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The radiotherapy quality assurance gap among phase III cancer clinical trials.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2022
    Trial
  4. Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2020
    Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Adoption of respiratory motion management in radiation therapy.Physics and imaging in radiation oncology · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Recommendations for Multicentre Clinical Trials Involving Dosimetry for Molecular Radiotherapy.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Christos MelidisEORTC - ROG, QART, Brussels, Belgium. Electronic address: Christos.Melidis@eortc.be.
Walter R BoschITC, Radiation Oncology, St. Louis, USA.
Joanna IzewskaIAEA, Dosimetry Laboratory, Vienna, Austria.
Elena FidarovaIAEA, Applied Radiation Biology and Radiotherapy Section, Vienna, Austria.
Eduardo ZubizarretaIAEA, Applied Radiation Biology and Radiotherapy Section, Vienna, Austria.
Satoshi IshikuraJCOG, QART, Tokyo, Japan.
David FollowillRPC, RTQA, Houston, USA.
James GalvinRTOG, RTQA, Philadelphia, USA.
Ying XiaoRTOG, RTQA, Philadelphia, USA.
Martin A EbertSWAN Development Group, University of Western Australia, Perth, Australia.
Tomas KronTROG, RTQA, Newcastle, Australia.
Catharine H ClarkRTTQA, UK.
Elizabeth A MilesRTTQA, UK.
Edwin G A AirdRTTQA, UK.
Damien C WeberEORTC - ROG, QART, Brussels, Belgium.
Kenneth UlinQARC, USA.
Dirk VerellenVrije Universiteit Brussel, Brussels, Belgium.
Coen W HurkmansEORTC - ROG, QART, Brussels, Belgium.

Funding

IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
RADIOLOGICAL PHYSICS CENTERU10CA010953 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FOLLOWILL, DAVID S · 1985 to 2013
$34.5M
QUALITY ASSURANCE REVIEW CENTER (QARC)U10CA029511 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, THOMAS J. · 1985 to 2013
$23.4M
NCI NIH HHS U10 CA010953NCI NIH HHS U10 CA029511NCI NIH HHS U24 CA180803
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicHumansNeoplasmsQuality Assurance, Health CareRadiation OncologyRadiotherapy

Identifiers

PMID24813094
PMCPMC4283479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.